AVYIA’s recommended weapon against mental health illnesses.
Free initial consultation, intake, history and physical.
$3,000 for a course of 6 treatment sessions.
$3,450 for a course of 3 treatment sessions with ketamine assisted therapy.
$450 for each additional booster session after a standard course.
$150 for each additional ketamine assisted therapy session.
Immediately, seconds to minutes
100%
40 minutes
30-60 minutes
90-120 minutes.
Varies from person to person based on body weight, medical and medication history.
Intravenous (IV) ketamine is the gold-standard of ketamine therapies for treating mental health disorders, OCD, and migraines. With AVYIA’s seasoned healthcare professionals, you can now undergo these treatments in the privacy and comfort of your home. For enhanced benefits, consider integrating ketamine-assisted therapy into your infusion sessions. This therapy involves a structured session overseen by a certified therapist. Research suggests that a series of six IV treatments spread over three weeks can lead to significant improvements, with some patients achieving total remission. Incorporating ketamine-assisted therapy can further optimize these outcomes.
The treatment’s dissociative and psychedelic characteristics are believed to encourage neuroplasticity, aiding in the restoration of compromised brain connections. A wealth of patient testimonials supports the efficacy of this approach. While the initial series of treatments can be transformative, occasional follow-up sessions might be required. Nonetheless, the intravenous method stands out as the most rapid and potent means to achieve full recovery from mental health challenges.
The dissociative and psychedelic properties are theorized to promote neuroplasticity, or the reconnecting of damaged brain pathways. Numerous anecdotal patient reports attest to the effectiveness of this treatment modality, but the body of science behind ketamine is also robust and impressive. Periodic booster sessions may be needed after the initial course of treatment; however, the intravenous route appears to be the fastest and most powerful method in achieving complete remission of one’s mental health disorders.
Ketamine is a member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group. Ketamine was originally developed as an anesthetic, but has gained interest in recent years for its success in treating various mental health disorders. Research is ongoing, but here's what we know about ketamine's effects and abilities to treat mental health disorders:
One of the most prominent features of ketamine when used to treat depression, especially treatment-resistant depression, is its ability to produce rapid antidepressant effects, often within hours to a few days.
Ketamine is an antagonist of the N-methyl-D-aspartate (NMDA) receptor, a type of glutamate receptor. This action is believed to play a role in its antidepressant effects, though the precise mechanisms are still under study.
Ketamine is believed to enhance synaptic plasticity, the ability of synapses to strengthen or weaken over time. This enhancement can promote the formation of new neural connections, which can be beneficial for mental health.
Ketamine has been shown to increase the release of brain-derived neurotrophic factor (BDNF), a protein that supports the survival of existing neurons and encourages the growth and differentiation of new neurons and synapses.
Some research suggests that ketamine may temporarily reduce the connectivity between certain parts of the brain, which might help "reset" dysfunctional brain networks seen in depression.
There's emerging evidence that inflammation might play a role in mood disorders. Ketamine has shown potential anti-inflammatory effects that could contribute to its therapeutic benefits.
Ketamine has demonstrated a rapid reduction in suicidal ideation in some individuals, which is of particular interest for emergency psychiatric interventions.
Preliminary research suggests that, in addition to depression, ketamine may be beneficial in treating post-traumatic stress disorder (PTSD) and some anxiety disorders.
There's some evidence to suggest that ketamine may have neuroprotective effects, helping to protect the brain from stress-induced damage and reduce brain injury (TBI) and Ischemia.
Some studies have explored the use of ketamine for its rapid antidepressant effects in treating bipolar disorder and other mood disorders. Ketamine plays a role in offering mood-stabilizing benefits to mental health patients.
